Pediatric Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Vaccines: Perceptions and Attitudes From the Food and Drug Administration Public Commentary( )

Authorization of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccines for children has ushered in a new phase of the immunization campaign to address the pandemic but has been received with mixed responses from parents, children, and opinion leaders. Herein we consider perceptions a...

Descripción completa

Detalles Bibliográficos
Autores principales: Weitzman, Elissa R, Sherman, Amy C, Levy, Ofer
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Precision Vaccines Supplement
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9129203/
https://www.ncbi.nlm.nih.gov/pubmed/35579499
http://dx.doi.org/10.1093/cid/ciac343
_version_ 1784712700430909440
author Weitzman, Elissa R
Sherman, Amy C
Levy, Ofer
author_facet Weitzman, Elissa R
Sherman, Amy C
Levy, Ofer
author_sort Weitzman, Elissa R
collection PubMed
description Authorization of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccines for children has ushered in a new phase of the immunization campaign to address the pandemic but has been received with mixed responses from parents, children, and opinion leaders. Herein we consider perceptions and attitudes towards pediatric SARS-CoV-2 vaccines from a Food and Drug Administration (FDA) public commentary reflecting more than 63 000 comments.
format Online
Article
Text
id pubmed-9129203
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-91292032022-05-25 Pediatric Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Vaccines: Perceptions and Attitudes From the Food and Drug Administration Public Commentary( ) Weitzman, Elissa R Sherman, Amy C Levy, Ofer Clin Infect Dis Precision Vaccines Supplement Authorization of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccines for children has ushered in a new phase of the immunization campaign to address the pandemic but has been received with mixed responses from parents, children, and opinion leaders. Herein we consider perceptions and attitudes towards pediatric SARS-CoV-2 vaccines from a Food and Drug Administration (FDA) public commentary reflecting more than 63 000 comments. Oxford University Press 2022-05-17 /pmc/articles/PMC9129203/ /pubmed/35579499 http://dx.doi.org/10.1093/cid/ciac343 Text en © The Author(s) 2022. Published by Oxford University Press on behalf of the Infectious Diseases Society of America. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (https://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
spellingShingle Precision Vaccines Supplement
Weitzman, Elissa R
Sherman, Amy C
Levy, Ofer
Pediatric Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Vaccines: Perceptions and Attitudes From the Food and Drug Administration Public Commentary( )
title Pediatric Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Vaccines: Perceptions and Attitudes From the Food and Drug Administration Public Commentary( )
title_full Pediatric Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Vaccines: Perceptions and Attitudes From the Food and Drug Administration Public Commentary( )
title_fullStr Pediatric Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Vaccines: Perceptions and Attitudes From the Food and Drug Administration Public Commentary( )
title_full_unstemmed Pediatric Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Vaccines: Perceptions and Attitudes From the Food and Drug Administration Public Commentary( )
title_short Pediatric Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Vaccines: Perceptions and Attitudes From the Food and Drug Administration Public Commentary( )
title_sort pediatric severe acute respiratory syndrome coronavirus 2 (sars-cov-2) vaccines: perceptions and attitudes from the food and drug administration public commentary( )
topic Precision Vaccines Supplement
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9129203/
https://www.ncbi.nlm.nih.gov/pubmed/35579499
http://dx.doi.org/10.1093/cid/ciac343
work_keys_str_mv AT weitzmanelissar pediatricsevereacuterespiratorysyndromecoronavirus2sarscov2vaccinesperceptionsandattitudesfromthefoodanddrugadministrationpubliccommentary
AT shermanamyc pediatricsevereacuterespiratorysyndromecoronavirus2sarscov2vaccinesperceptionsandattitudesfromthefoodanddrugadministrationpubliccommentary
AT levyofer pediatricsevereacuterespiratorysyndromecoronavirus2sarscov2vaccinesperceptionsandattitudesfromthefoodanddrugadministrationpubliccommentary

Ejemplares similares